Transition of cancer survivors diagnosed with hereditary tumors

Transition of cancer survivors diagnosed with hereditary tumors - Transition of cancer survivors diagnosed with hereditary tumors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000057529

Enrollment

Registered

2026-04-01

Start date

2022-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) The patient has been diagnosed with cancer and more than 4 months have passed since the completion of anticancer drug treatment, surgery, or radiation therapy. 2) The patient has been diagnosed with a hereditary tumor based on a genetic test or clinical diagnosis after being diagnosed with cancer, and it has been less than 6 years since the diagnosis of hereditary tumor. 3) The patient is able to speak Japanese and is aware that he/she is physically able to meet in person or online for a one-hour interview.

Exclusion criteria

Exclusion criteria: Non

Design outcomes

Primary

Measure	Time frame
Non	—

Countries

Japan

Contacts

Public ContactSatoko MIYAWAKI

Shikoku Cancer Center Nursing-Dep

sattinlovesminmin@yahoo.co.jp09048947649

Outcome results